ACOG (Alpha Cognition) Short Interest


ACOG Alpha Cognition Inc ACOG
32 GF Score
Price $6.59
! 3 Warning Signs
View Full Analysis

What is Alpha Cognition Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


ACOG vs GNLX, VTVT, CRDF: Short Interest Comparison

For the Biotechnology subindustry, Alpha Cognition's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Cognition Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Cognition's Short Interest distribution charts can be found below:

* The bar in red indicates where Alpha Cognition's Short Interest falls into.


ACOG
32GF Score
Alpha Cognition Inc ACOG
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Cognition Business Description

Other Exchanges 7N70:Germany
Address 1200 - 750 West Pender Street, Vancouver, BC, CAN, V6C 2T8
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
32GF Score

Get the complete analysis for ACOG

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.59
Price